nodes	percent_of_prediction	percent_of_DWPC	metapath
Quetiapine—Promazine—Tamoxifen—pancreatic cancer	0.154	1	CrCrCtD
Quetiapine—CYP3A7-CYP3A51P—Tamoxifen—pancreatic cancer	0.0303	0.0719	CbGbCtD
Quetiapine—CYP3A7—Tamoxifen—pancreatic cancer	0.0303	0.0719	CbGbCtD
Quetiapine—CYP3A7-CYP3A51P—Irinotecan—pancreatic cancer	0.0233	0.0552	CbGbCtD
Quetiapine—CYP3A7—Irinotecan—pancreatic cancer	0.0233	0.0552	CbGbCtD
Quetiapine—CYP3A5—Tamoxifen—pancreatic cancer	0.0227	0.0539	CbGbCtD
Quetiapine—CYP3A5—Erlotinib—pancreatic cancer	0.0193	0.0459	CbGbCtD
Quetiapine—CYP2C19—Tamoxifen—pancreatic cancer	0.0183	0.0435	CbGbCtD
Quetiapine—CYP3A5—Irinotecan—pancreatic cancer	0.0175	0.0414	CbGbCtD
Quetiapine—CYP3A7-CYP3A51P—Docetaxel—pancreatic cancer	0.0171	0.0405	CbGbCtD
Quetiapine—CYP3A7—Docetaxel—pancreatic cancer	0.0171	0.0405	CbGbCtD
Quetiapine—CYP3A7-CYP3A51P—Sunitinib—pancreatic cancer	0.017	0.0403	CbGbCtD
Quetiapine—CYP3A7—Sunitinib—pancreatic cancer	0.017	0.0403	CbGbCtD
Quetiapine—ABCB1—Tamoxifen—pancreatic cancer	0.0148	0.0351	CbGbCtD
Quetiapine—CYP2D6—Tamoxifen—pancreatic cancer	0.0139	0.0331	CbGbCtD
Quetiapine—CYP3A5—Docetaxel—pancreatic cancer	0.0128	0.0304	CbGbCtD
Quetiapine—ABCB1—Gemcitabine—pancreatic cancer	0.0128	0.0302	CbGbCtD
Quetiapine—CYP3A5—Sunitinib—pancreatic cancer	0.0127	0.0302	CbGbCtD
Quetiapine—ABCB1—Erlotinib—pancreatic cancer	0.0126	0.0299	CbGbCtD
Quetiapine—CYP2D6—Erlotinib—pancreatic cancer	0.0119	0.0281	CbGbCtD
Quetiapine—HTR3A—enteric nervous system—pancreatic cancer	0.0115	0.342	CbGeAlD
Quetiapine—ABCB1—Irinotecan—pancreatic cancer	0.0114	0.027	CbGbCtD
Quetiapine—CYP3A4—Tamoxifen—pancreatic cancer	0.00887	0.021	CbGbCtD
Quetiapine—ABCB1—Docetaxel—pancreatic cancer	0.00833	0.0198	CbGbCtD
Quetiapine—ABCB1—Sunitinib—pancreatic cancer	0.00829	0.0197	CbGbCtD
Quetiapine—CYP3A4—Erlotinib—pancreatic cancer	0.00754	0.0179	CbGbCtD
Quetiapine—HTR7—enteric nervous system—pancreatic cancer	0.00743	0.221	CbGeAlD
Quetiapine—CYP3A4—Irinotecan—pancreatic cancer	0.00681	0.0162	CbGbCtD
Quetiapine—ABCB1—Doxorubicin—pancreatic cancer	0.00621	0.0147	CbGbCtD
Quetiapine—CYP2D6—Doxorubicin—pancreatic cancer	0.00585	0.0139	CbGbCtD
Quetiapine—CYP3A4—Docetaxel—pancreatic cancer	0.00499	0.0118	CbGbCtD
Quetiapine—CYP3A4—Sunitinib—pancreatic cancer	0.00497	0.0118	CbGbCtD
Quetiapine—HTR2A—enteric nervous system—pancreatic cancer	0.00463	0.138	CbGeAlD
Quetiapine—CYP3A4—Doxorubicin—pancreatic cancer	0.00372	0.00882	CbGbCtD
Quetiapine—H1F0—islet of Langerhans—pancreatic cancer	0.00115	0.0343	CbGeAlD
Quetiapine—HTR3A—islet of Langerhans—pancreatic cancer	0.0011	0.0327	CbGeAlD
Quetiapine—H1F0—pancreas—pancreatic cancer	0.000809	0.0241	CbGeAlD
Quetiapine—H1F0—digestive system—pancreatic cancer	0.000691	0.0206	CbGeAlD
Quetiapine—HTR3A—digestive system—pancreatic cancer	0.000659	0.0196	CbGeAlD
Quetiapine—CYP3A5—islet of Langerhans—pancreatic cancer	0.000546	0.0163	CbGeAlD
Quetiapine—ADRA2A—islet of Langerhans—pancreatic cancer	0.000521	0.0155	CbGeAlD
Quetiapine—ADRA2C—pancreas—pancreatic cancer	0.000459	0.0137	CbGeAlD
Quetiapine—CHRM3—digestive system—pancreatic cancer	0.000448	0.0133	CbGeAlD
Quetiapine—HTR7—digestive system—pancreatic cancer	0.000426	0.0127	CbGeAlD
Quetiapine—CYP2C19—digestive system—pancreatic cancer	0.000416	0.0124	CbGeAlD
Quetiapine—CYP3A5—pancreas—pancreatic cancer	0.000384	0.0114	CbGeAlD
Quetiapine—ADRA2A—pancreas—pancreatic cancer	0.000366	0.0109	CbGeAlD
Quetiapine—CYP3A5—digestive system—pancreatic cancer	0.000328	0.00976	CbGeAlD
Quetiapine—HRH1—digestive system—pancreatic cancer	0.000318	0.00948	CbGeAlD
Quetiapine—ABCB1—islet of Langerhans—pancreatic cancer	0.00029	0.00864	CbGeAlD
Quetiapine—HTR2A—digestive system—pancreatic cancer	0.000266	0.00792	CbGeAlD
Quetiapine—CYP3A4—digestive system—pancreatic cancer	0.000246	0.00733	CbGeAlD
Quetiapine—CYP2D6—digestive system—pancreatic cancer	0.000242	0.00721	CbGeAlD
Quetiapine—ABCB1—pancreas—pancreatic cancer	0.000204	0.00607	CbGeAlD
Quetiapine—ABCB1—digestive system—pancreatic cancer	0.000174	0.00519	CbGeAlD
Quetiapine—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	8.81e-05	0.000383	CcSEcCtD
Quetiapine—Sweating—Epirubicin—pancreatic cancer	8.76e-05	0.000381	CcSEcCtD
Quetiapine—Pollakiuria—Doxorubicin—pancreatic cancer	8.76e-05	0.000381	CcSEcCtD
Quetiapine—Asthenia—Gemcitabine—pancreatic cancer	8.73e-05	0.00038	CcSEcCtD
Quetiapine—Confusional state—Docetaxel—pancreatic cancer	8.71e-05	0.000379	CcSEcCtD
Quetiapine—Photosensitivity reaction—Doxorubicin—pancreatic cancer	8.65e-05	0.000376	CcSEcCtD
Quetiapine—Hepatobiliary disease—Epirubicin—pancreatic cancer	8.64e-05	0.000376	CcSEcCtD
Quetiapine—Anaphylactic shock—Docetaxel—pancreatic cancer	8.64e-05	0.000375	CcSEcCtD
Quetiapine—Weight increased—Doxorubicin—pancreatic cancer	8.63e-05	0.000375	CcSEcCtD
Quetiapine—Epistaxis—Epirubicin—pancreatic cancer	8.61e-05	0.000375	CcSEcCtD
Quetiapine—Pruritus—Gemcitabine—pancreatic cancer	8.61e-05	0.000374	CcSEcCtD
Quetiapine—Infection—Docetaxel—pancreatic cancer	8.58e-05	0.000373	CcSEcCtD
Quetiapine—Weight decreased—Doxorubicin—pancreatic cancer	8.57e-05	0.000373	CcSEcCtD
Quetiapine—Sinusitis—Epirubicin—pancreatic cancer	8.57e-05	0.000373	CcSEcCtD
Quetiapine—Hyperglycaemia—Doxorubicin—pancreatic cancer	8.55e-05	0.000372	CcSEcCtD
Quetiapine—Diarrhoea—Irinotecan—pancreatic cancer	8.55e-05	0.000372	CcSEcCtD
Quetiapine—Agranulocytosis—Epirubicin—pancreatic cancer	8.52e-05	0.000371	CcSEcCtD
Quetiapine—Pneumonia—Doxorubicin—pancreatic cancer	8.5e-05	0.00037	CcSEcCtD
Quetiapine—Shock—Docetaxel—pancreatic cancer	8.5e-05	0.000369	CcSEcCtD
Quetiapine—Nervous system disorder—Docetaxel—pancreatic cancer	8.47e-05	0.000368	CcSEcCtD
Quetiapine—Pruritus—Fluorouracil—pancreatic cancer	8.47e-05	0.000368	CcSEcCtD
Quetiapine—Thrombocytopenia—Docetaxel—pancreatic cancer	8.46e-05	0.000368	CcSEcCtD
Quetiapine—Infestation NOS—Doxorubicin—pancreatic cancer	8.45e-05	0.000367	CcSEcCtD
Quetiapine—Infestation—Doxorubicin—pancreatic cancer	8.45e-05	0.000367	CcSEcCtD
Quetiapine—Tachycardia—Docetaxel—pancreatic cancer	8.43e-05	0.000366	CcSEcCtD
Quetiapine—Skin disorder—Docetaxel—pancreatic cancer	8.39e-05	0.000365	CcSEcCtD
Quetiapine—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	8.38e-05	0.000364	CcSEcCtD
Quetiapine—Bradycardia—Epirubicin—pancreatic cancer	8.35e-05	0.000363	CcSEcCtD
Quetiapine—Diarrhoea—Gemcitabine—pancreatic cancer	8.33e-05	0.000362	CcSEcCtD
Quetiapine—Dizziness—Irinotecan—pancreatic cancer	8.26e-05	0.000359	CcSEcCtD
Quetiapine—Haemoglobin—Epirubicin—pancreatic cancer	8.24e-05	0.000358	CcSEcCtD
Quetiapine—Stomatitis—Doxorubicin—pancreatic cancer	8.24e-05	0.000358	CcSEcCtD
Quetiapine—Jaundice—Doxorubicin—pancreatic cancer	8.24e-05	0.000358	CcSEcCtD
Quetiapine—Anorexia—Docetaxel—pancreatic cancer	8.23e-05	0.000358	CcSEcCtD
Quetiapine—Rhinitis—Epirubicin—pancreatic cancer	8.22e-05	0.000357	CcSEcCtD
Quetiapine—Conjunctivitis—Doxorubicin—pancreatic cancer	8.21e-05	0.000357	CcSEcCtD
Quetiapine—Urinary tract infection—Doxorubicin—pancreatic cancer	8.21e-05	0.000357	CcSEcCtD
Quetiapine—Hepatitis—Epirubicin—pancreatic cancer	8.2e-05	0.000356	CcSEcCtD
Quetiapine—Haemorrhage—Epirubicin—pancreatic cancer	8.2e-05	0.000356	CcSEcCtD
Quetiapine—Diarrhoea—Fluorouracil—pancreatic cancer	8.19e-05	0.000356	CcSEcCtD
Quetiapine—Hypoaesthesia—Epirubicin—pancreatic cancer	8.16e-05	0.000355	CcSEcCtD
Quetiapine—Pharyngitis—Epirubicin—pancreatic cancer	8.14e-05	0.000354	CcSEcCtD
Quetiapine—Sweating—Doxorubicin—pancreatic cancer	8.1e-05	0.000352	CcSEcCtD
Quetiapine—Urinary tract disorder—Epirubicin—pancreatic cancer	8.1e-05	0.000352	CcSEcCtD
Quetiapine—Oedema peripheral—Epirubicin—pancreatic cancer	8.08e-05	0.000351	CcSEcCtD
Quetiapine—Hypotension—Docetaxel—pancreatic cancer	8.07e-05	0.000351	CcSEcCtD
Quetiapine—Connective tissue disorder—Epirubicin—pancreatic cancer	8.06e-05	0.00035	CcSEcCtD
Quetiapine—Urethral disorder—Epirubicin—pancreatic cancer	8.04e-05	0.000349	CcSEcCtD
Quetiapine—Hepatobiliary disease—Doxorubicin—pancreatic cancer	7.99e-05	0.000347	CcSEcCtD
Quetiapine—Epistaxis—Doxorubicin—pancreatic cancer	7.97e-05	0.000347	CcSEcCtD
Quetiapine—Vomiting—Irinotecan—pancreatic cancer	7.94e-05	0.000345	CcSEcCtD
Quetiapine—Sinusitis—Doxorubicin—pancreatic cancer	7.93e-05	0.000345	CcSEcCtD
Quetiapine—Dizziness—Fluorouracil—pancreatic cancer	7.91e-05	0.000344	CcSEcCtD
Quetiapine—Visual impairment—Epirubicin—pancreatic cancer	7.9e-05	0.000344	CcSEcCtD
Quetiapine—Agranulocytosis—Doxorubicin—pancreatic cancer	7.89e-05	0.000343	CcSEcCtD
Quetiapine—Rash—Irinotecan—pancreatic cancer	7.88e-05	0.000342	CcSEcCtD
Quetiapine—Dermatitis—Irinotecan—pancreatic cancer	7.87e-05	0.000342	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	7.87e-05	0.000342	CcSEcCtD
Quetiapine—Headache—Irinotecan—pancreatic cancer	7.83e-05	0.00034	CcSEcCtD
Quetiapine—Insomnia—Docetaxel—pancreatic cancer	7.81e-05	0.00034	CcSEcCtD
Quetiapine—Paraesthesia—Docetaxel—pancreatic cancer	7.75e-05	0.000337	CcSEcCtD
Quetiapine—Erythema multiforme—Epirubicin—pancreatic cancer	7.75e-05	0.000337	CcSEcCtD
Quetiapine—Vomiting—Gemcitabine—pancreatic cancer	7.74e-05	0.000336	CcSEcCtD
Quetiapine—Bradycardia—Doxorubicin—pancreatic cancer	7.72e-05	0.000336	CcSEcCtD
Quetiapine—Dyspnoea—Docetaxel—pancreatic cancer	7.7e-05	0.000335	CcSEcCtD
Quetiapine—Somnolence—Docetaxel—pancreatic cancer	7.68e-05	0.000334	CcSEcCtD
Quetiapine—Rash—Gemcitabine—pancreatic cancer	7.67e-05	0.000334	CcSEcCtD
Quetiapine—Dermatitis—Gemcitabine—pancreatic cancer	7.67e-05	0.000333	CcSEcCtD
Quetiapine—Eye disorder—Epirubicin—pancreatic cancer	7.66e-05	0.000333	CcSEcCtD
Quetiapine—Tinnitus—Epirubicin—pancreatic cancer	7.64e-05	0.000332	CcSEcCtD
Quetiapine—Haemoglobin—Doxorubicin—pancreatic cancer	7.62e-05	0.000332	CcSEcCtD
Quetiapine—Headache—Gemcitabine—pancreatic cancer	7.62e-05	0.000331	CcSEcCtD
Quetiapine—Cardiac disorder—Epirubicin—pancreatic cancer	7.61e-05	0.000331	CcSEcCtD
Quetiapine—Vomiting—Fluorouracil—pancreatic cancer	7.61e-05	0.000331	CcSEcCtD
Quetiapine—Rhinitis—Doxorubicin—pancreatic cancer	7.61e-05	0.000331	CcSEcCtD
Quetiapine—Dyspepsia—Docetaxel—pancreatic cancer	7.6e-05	0.000331	CcSEcCtD
Quetiapine—Haemorrhage—Doxorubicin—pancreatic cancer	7.59e-05	0.00033	CcSEcCtD
Quetiapine—Hepatitis—Doxorubicin—pancreatic cancer	7.59e-05	0.00033	CcSEcCtD
Quetiapine—Hypoaesthesia—Doxorubicin—pancreatic cancer	7.55e-05	0.000328	CcSEcCtD
Quetiapine—Rash—Fluorouracil—pancreatic cancer	7.54e-05	0.000328	CcSEcCtD
Quetiapine—Dermatitis—Fluorouracil—pancreatic cancer	7.54e-05	0.000328	CcSEcCtD
Quetiapine—Pharyngitis—Doxorubicin—pancreatic cancer	7.53e-05	0.000327	CcSEcCtD
Quetiapine—Decreased appetite—Docetaxel—pancreatic cancer	7.51e-05	0.000326	CcSEcCtD
Quetiapine—Headache—Fluorouracil—pancreatic cancer	7.5e-05	0.000326	CcSEcCtD
Quetiapine—Urinary tract disorder—Doxorubicin—pancreatic cancer	7.49e-05	0.000326	CcSEcCtD
Quetiapine—Oedema peripheral—Doxorubicin—pancreatic cancer	7.47e-05	0.000325	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Docetaxel—pancreatic cancer	7.46e-05	0.000324	CcSEcCtD
Quetiapine—Connective tissue disorder—Doxorubicin—pancreatic cancer	7.45e-05	0.000324	CcSEcCtD
Quetiapine—Fatigue—Docetaxel—pancreatic cancer	7.45e-05	0.000324	CcSEcCtD
Quetiapine—Angiopathy—Epirubicin—pancreatic cancer	7.44e-05	0.000323	CcSEcCtD
Quetiapine—Urethral disorder—Doxorubicin—pancreatic cancer	7.44e-05	0.000323	CcSEcCtD
Quetiapine—Nausea—Irinotecan—pancreatic cancer	7.42e-05	0.000323	CcSEcCtD
Quetiapine—Immune system disorder—Epirubicin—pancreatic cancer	7.41e-05	0.000322	CcSEcCtD
Quetiapine—Mediastinal disorder—Epirubicin—pancreatic cancer	7.39e-05	0.000321	CcSEcCtD
Quetiapine—Pain—Docetaxel—pancreatic cancer	7.38e-05	0.000321	CcSEcCtD
Quetiapine—Constipation—Docetaxel—pancreatic cancer	7.38e-05	0.000321	CcSEcCtD
Quetiapine—Chills—Epirubicin—pancreatic cancer	7.36e-05	0.00032	CcSEcCtD
Quetiapine—Visual impairment—Doxorubicin—pancreatic cancer	7.31e-05	0.000318	CcSEcCtD
Quetiapine—Nausea—Gemcitabine—pancreatic cancer	7.23e-05	0.000314	CcSEcCtD
Quetiapine—Mental disorder—Epirubicin—pancreatic cancer	7.18e-05	0.000312	CcSEcCtD
Quetiapine—Erythema multiforme—Doxorubicin—pancreatic cancer	7.17e-05	0.000312	CcSEcCtD
Quetiapine—Malnutrition—Epirubicin—pancreatic cancer	7.14e-05	0.00031	CcSEcCtD
Quetiapine—Feeling abnormal—Docetaxel—pancreatic cancer	7.12e-05	0.000309	CcSEcCtD
Quetiapine—Nausea—Fluorouracil—pancreatic cancer	7.11e-05	0.000309	CcSEcCtD
Quetiapine—Eye disorder—Doxorubicin—pancreatic cancer	7.09e-05	0.000308	CcSEcCtD
Quetiapine—Tinnitus—Doxorubicin—pancreatic cancer	7.07e-05	0.000308	CcSEcCtD
Quetiapine—Gastrointestinal pain—Docetaxel—pancreatic cancer	7.06e-05	0.000307	CcSEcCtD
Quetiapine—Cardiac disorder—Doxorubicin—pancreatic cancer	7.04e-05	0.000306	CcSEcCtD
Quetiapine—Flatulence—Epirubicin—pancreatic cancer	7.03e-05	0.000306	CcSEcCtD
Quetiapine—Tension—Epirubicin—pancreatic cancer	7e-05	0.000305	CcSEcCtD
Quetiapine—Dysgeusia—Epirubicin—pancreatic cancer	6.99e-05	0.000304	CcSEcCtD
Quetiapine—Nervousness—Epirubicin—pancreatic cancer	6.93e-05	0.000301	CcSEcCtD
Quetiapine—Back pain—Epirubicin—pancreatic cancer	6.9e-05	0.0003	CcSEcCtD
Quetiapine—Angiopathy—Doxorubicin—pancreatic cancer	6.88e-05	0.000299	CcSEcCtD
Quetiapine—Muscle spasms—Epirubicin—pancreatic cancer	6.86e-05	0.000298	CcSEcCtD
Quetiapine—Immune system disorder—Doxorubicin—pancreatic cancer	6.85e-05	0.000298	CcSEcCtD
Quetiapine—Mediastinal disorder—Doxorubicin—pancreatic cancer	6.84e-05	0.000297	CcSEcCtD
Quetiapine—Abdominal pain—Docetaxel—pancreatic cancer	6.83e-05	0.000297	CcSEcCtD
Quetiapine—Body temperature increased—Docetaxel—pancreatic cancer	6.83e-05	0.000297	CcSEcCtD
Quetiapine—Chills—Doxorubicin—pancreatic cancer	6.81e-05	0.000296	CcSEcCtD
Quetiapine—Vision blurred—Epirubicin—pancreatic cancer	6.73e-05	0.000292	CcSEcCtD
Quetiapine—Mental disorder—Doxorubicin—pancreatic cancer	6.65e-05	0.000289	CcSEcCtD
Quetiapine—Ill-defined disorder—Epirubicin—pancreatic cancer	6.62e-05	0.000288	CcSEcCtD
Quetiapine—Malnutrition—Doxorubicin—pancreatic cancer	6.6e-05	0.000287	CcSEcCtD
Quetiapine—Anaemia—Epirubicin—pancreatic cancer	6.6e-05	0.000287	CcSEcCtD
Quetiapine—Agitation—Epirubicin—pancreatic cancer	6.56e-05	0.000285	CcSEcCtD
Quetiapine—Flatulence—Doxorubicin—pancreatic cancer	6.51e-05	0.000283	CcSEcCtD
Quetiapine—Tension—Doxorubicin—pancreatic cancer	6.48e-05	0.000282	CcSEcCtD
Quetiapine—Dysgeusia—Doxorubicin—pancreatic cancer	6.47e-05	0.000281	CcSEcCtD
Quetiapine—Malaise—Epirubicin—pancreatic cancer	6.44e-05	0.00028	CcSEcCtD
Quetiapine—Nervousness—Doxorubicin—pancreatic cancer	6.41e-05	0.000279	CcSEcCtD
Quetiapine—Vertigo—Epirubicin—pancreatic cancer	6.41e-05	0.000279	CcSEcCtD
Quetiapine—Syncope—Epirubicin—pancreatic cancer	6.4e-05	0.000278	CcSEcCtD
Quetiapine—Leukopenia—Epirubicin—pancreatic cancer	6.39e-05	0.000278	CcSEcCtD
Quetiapine—Back pain—Doxorubicin—pancreatic cancer	6.39e-05	0.000278	CcSEcCtD
Quetiapine—Hypersensitivity—Docetaxel—pancreatic cancer	6.36e-05	0.000277	CcSEcCtD
Quetiapine—Muscle spasms—Doxorubicin—pancreatic cancer	6.35e-05	0.000276	CcSEcCtD
Quetiapine—Palpitations—Epirubicin—pancreatic cancer	6.31e-05	0.000274	CcSEcCtD
Quetiapine—Loss of consciousness—Epirubicin—pancreatic cancer	6.27e-05	0.000273	CcSEcCtD
Quetiapine—Cough—Epirubicin—pancreatic cancer	6.23e-05	0.000271	CcSEcCtD
Quetiapine—Vision blurred—Doxorubicin—pancreatic cancer	6.22e-05	0.000271	CcSEcCtD
Quetiapine—Asthenia—Docetaxel—pancreatic cancer	6.2e-05	0.000269	CcSEcCtD
Quetiapine—Convulsion—Epirubicin—pancreatic cancer	6.18e-05	0.000269	CcSEcCtD
Quetiapine—Hypertension—Epirubicin—pancreatic cancer	6.16e-05	0.000268	CcSEcCtD
Quetiapine—Ill-defined disorder—Doxorubicin—pancreatic cancer	6.13e-05	0.000266	CcSEcCtD
Quetiapine—Pruritus—Docetaxel—pancreatic cancer	6.11e-05	0.000266	CcSEcCtD
Quetiapine—Anaemia—Doxorubicin—pancreatic cancer	6.1e-05	0.000265	CcSEcCtD
Quetiapine—Arthralgia—Epirubicin—pancreatic cancer	6.08e-05	0.000264	CcSEcCtD
Quetiapine—Myalgia—Epirubicin—pancreatic cancer	6.08e-05	0.000264	CcSEcCtD
Quetiapine—Chest pain—Epirubicin—pancreatic cancer	6.08e-05	0.000264	CcSEcCtD
Quetiapine—Agitation—Doxorubicin—pancreatic cancer	6.07e-05	0.000264	CcSEcCtD
Quetiapine—Anxiety—Epirubicin—pancreatic cancer	6.06e-05	0.000263	CcSEcCtD
Quetiapine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	6.03e-05	0.000262	CcSEcCtD
Quetiapine—Discomfort—Epirubicin—pancreatic cancer	6e-05	0.000261	CcSEcCtD
Quetiapine—Malaise—Doxorubicin—pancreatic cancer	5.96e-05	0.000259	CcSEcCtD
Quetiapine—Dry mouth—Epirubicin—pancreatic cancer	5.94e-05	0.000258	CcSEcCtD
Quetiapine—Vertigo—Doxorubicin—pancreatic cancer	5.93e-05	0.000258	CcSEcCtD
Quetiapine—Syncope—Doxorubicin—pancreatic cancer	5.92e-05	0.000257	CcSEcCtD
Quetiapine—Leukopenia—Doxorubicin—pancreatic cancer	5.91e-05	0.000257	CcSEcCtD
Quetiapine—Diarrhoea—Docetaxel—pancreatic cancer	5.91e-05	0.000257	CcSEcCtD
Quetiapine—Confusional state—Epirubicin—pancreatic cancer	5.87e-05	0.000255	CcSEcCtD
Quetiapine—Palpitations—Doxorubicin—pancreatic cancer	5.84e-05	0.000254	CcSEcCtD
Quetiapine—Anaphylactic shock—Epirubicin—pancreatic cancer	5.82e-05	0.000253	CcSEcCtD
Quetiapine—Loss of consciousness—Doxorubicin—pancreatic cancer	5.8e-05	0.000252	CcSEcCtD
Quetiapine—Infection—Epirubicin—pancreatic cancer	5.79e-05	0.000252	CcSEcCtD
Quetiapine—Cough—Doxorubicin—pancreatic cancer	5.76e-05	0.000251	CcSEcCtD
Quetiapine—Shock—Epirubicin—pancreatic cancer	5.73e-05	0.000249	CcSEcCtD
Quetiapine—Convulsion—Doxorubicin—pancreatic cancer	5.72e-05	0.000249	CcSEcCtD
Quetiapine—Nervous system disorder—Epirubicin—pancreatic cancer	5.71e-05	0.000248	CcSEcCtD
Quetiapine—Dizziness—Docetaxel—pancreatic cancer	5.71e-05	0.000248	CcSEcCtD
Quetiapine—Thrombocytopenia—Epirubicin—pancreatic cancer	5.7e-05	0.000248	CcSEcCtD
Quetiapine—Hypertension—Doxorubicin—pancreatic cancer	5.7e-05	0.000248	CcSEcCtD
Quetiapine—Tachycardia—Epirubicin—pancreatic cancer	5.68e-05	0.000247	CcSEcCtD
Quetiapine—Skin disorder—Epirubicin—pancreatic cancer	5.66e-05	0.000246	CcSEcCtD
Quetiapine—Hyperhidrosis—Epirubicin—pancreatic cancer	5.63e-05	0.000245	CcSEcCtD
Quetiapine—Myalgia—Doxorubicin—pancreatic cancer	5.62e-05	0.000244	CcSEcCtD
Quetiapine—Arthralgia—Doxorubicin—pancreatic cancer	5.62e-05	0.000244	CcSEcCtD
Quetiapine—Chest pain—Doxorubicin—pancreatic cancer	5.62e-05	0.000244	CcSEcCtD
Quetiapine—Anxiety—Doxorubicin—pancreatic cancer	5.6e-05	0.000244	CcSEcCtD
Quetiapine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	5.58e-05	0.000243	CcSEcCtD
Quetiapine—Discomfort—Doxorubicin—pancreatic cancer	5.55e-05	0.000242	CcSEcCtD
Quetiapine—Anorexia—Epirubicin—pancreatic cancer	5.55e-05	0.000241	CcSEcCtD
Quetiapine—Dry mouth—Doxorubicin—pancreatic cancer	5.5e-05	0.000239	CcSEcCtD
Quetiapine—Vomiting—Docetaxel—pancreatic cancer	5.49e-05	0.000239	CcSEcCtD
Quetiapine—Rash—Docetaxel—pancreatic cancer	5.45e-05	0.000237	CcSEcCtD
Quetiapine—Hypotension—Epirubicin—pancreatic cancer	5.44e-05	0.000237	CcSEcCtD
Quetiapine—Dermatitis—Docetaxel—pancreatic cancer	5.44e-05	0.000237	CcSEcCtD
Quetiapine—Confusional state—Doxorubicin—pancreatic cancer	5.43e-05	0.000236	CcSEcCtD
Quetiapine—Headache—Docetaxel—pancreatic cancer	5.41e-05	0.000235	CcSEcCtD
Quetiapine—Anaphylactic shock—Doxorubicin—pancreatic cancer	5.39e-05	0.000234	CcSEcCtD
Quetiapine—Infection—Doxorubicin—pancreatic cancer	5.35e-05	0.000233	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	5.31e-05	0.000231	CcSEcCtD
Quetiapine—Shock—Doxorubicin—pancreatic cancer	5.3e-05	0.000231	CcSEcCtD
Quetiapine—Nervous system disorder—Doxorubicin—pancreatic cancer	5.29e-05	0.00023	CcSEcCtD
Quetiapine—Thrombocytopenia—Doxorubicin—pancreatic cancer	5.28e-05	0.000229	CcSEcCtD
Quetiapine—Insomnia—Epirubicin—pancreatic cancer	5.27e-05	0.000229	CcSEcCtD
Quetiapine—Tachycardia—Doxorubicin—pancreatic cancer	5.26e-05	0.000229	CcSEcCtD
Quetiapine—Skin disorder—Doxorubicin—pancreatic cancer	5.24e-05	0.000228	CcSEcCtD
Quetiapine—Paraesthesia—Epirubicin—pancreatic cancer	5.23e-05	0.000227	CcSEcCtD
Quetiapine—Hyperhidrosis—Doxorubicin—pancreatic cancer	5.21e-05	0.000227	CcSEcCtD
Quetiapine—Dyspnoea—Epirubicin—pancreatic cancer	5.19e-05	0.000226	CcSEcCtD
Quetiapine—Somnolence—Epirubicin—pancreatic cancer	5.18e-05	0.000225	CcSEcCtD
Quetiapine—Anorexia—Doxorubicin—pancreatic cancer	5.14e-05	0.000223	CcSEcCtD
Quetiapine—Nausea—Docetaxel—pancreatic cancer	5.13e-05	0.000223	CcSEcCtD
Quetiapine—Dyspepsia—Epirubicin—pancreatic cancer	5.13e-05	0.000223	CcSEcCtD
Quetiapine—Decreased appetite—Epirubicin—pancreatic cancer	5.06e-05	0.00022	CcSEcCtD
Quetiapine—Hypotension—Doxorubicin—pancreatic cancer	5.04e-05	0.000219	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Epirubicin—pancreatic cancer	5.03e-05	0.000219	CcSEcCtD
Quetiapine—Fatigue—Epirubicin—pancreatic cancer	5.02e-05	0.000218	CcSEcCtD
Quetiapine—Constipation—Epirubicin—pancreatic cancer	4.98e-05	0.000217	CcSEcCtD
Quetiapine—Pain—Epirubicin—pancreatic cancer	4.98e-05	0.000217	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	4.91e-05	0.000213	CcSEcCtD
Quetiapine—Insomnia—Doxorubicin—pancreatic cancer	4.87e-05	0.000212	CcSEcCtD
Quetiapine—Paraesthesia—Doxorubicin—pancreatic cancer	4.84e-05	0.00021	CcSEcCtD
Quetiapine—Dyspnoea—Doxorubicin—pancreatic cancer	4.81e-05	0.000209	CcSEcCtD
Quetiapine—Feeling abnormal—Epirubicin—pancreatic cancer	4.8e-05	0.000209	CcSEcCtD
Quetiapine—Somnolence—Doxorubicin—pancreatic cancer	4.79e-05	0.000208	CcSEcCtD
Quetiapine—Gastrointestinal pain—Epirubicin—pancreatic cancer	4.76e-05	0.000207	CcSEcCtD
Quetiapine—Dyspepsia—Doxorubicin—pancreatic cancer	4.74e-05	0.000206	CcSEcCtD
Quetiapine—Decreased appetite—Doxorubicin—pancreatic cancer	4.69e-05	0.000204	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	4.65e-05	0.000202	CcSEcCtD
Quetiapine—Fatigue—Doxorubicin—pancreatic cancer	4.65e-05	0.000202	CcSEcCtD
Quetiapine—Pain—Doxorubicin—pancreatic cancer	4.61e-05	0.0002	CcSEcCtD
Quetiapine—Constipation—Doxorubicin—pancreatic cancer	4.61e-05	0.0002	CcSEcCtD
Quetiapine—Abdominal pain—Epirubicin—pancreatic cancer	4.6e-05	0.0002	CcSEcCtD
Quetiapine—Body temperature increased—Epirubicin—pancreatic cancer	4.6e-05	0.0002	CcSEcCtD
Quetiapine—Feeling abnormal—Doxorubicin—pancreatic cancer	4.44e-05	0.000193	CcSEcCtD
Quetiapine—Gastrointestinal pain—Doxorubicin—pancreatic cancer	4.41e-05	0.000192	CcSEcCtD
Quetiapine—Hypersensitivity—Epirubicin—pancreatic cancer	4.29e-05	0.000187	CcSEcCtD
Quetiapine—Body temperature increased—Doxorubicin—pancreatic cancer	4.26e-05	0.000185	CcSEcCtD
Quetiapine—Abdominal pain—Doxorubicin—pancreatic cancer	4.26e-05	0.000185	CcSEcCtD
Quetiapine—Asthenia—Epirubicin—pancreatic cancer	4.18e-05	0.000182	CcSEcCtD
Quetiapine—Pruritus—Epirubicin—pancreatic cancer	4.12e-05	0.000179	CcSEcCtD
Quetiapine—Diarrhoea—Epirubicin—pancreatic cancer	3.99e-05	0.000173	CcSEcCtD
Quetiapine—Hypersensitivity—Doxorubicin—pancreatic cancer	3.97e-05	0.000173	CcSEcCtD
Quetiapine—Asthenia—Doxorubicin—pancreatic cancer	3.87e-05	0.000168	CcSEcCtD
Quetiapine—Dizziness—Epirubicin—pancreatic cancer	3.85e-05	0.000167	CcSEcCtD
Quetiapine—Pruritus—Doxorubicin—pancreatic cancer	3.81e-05	0.000166	CcSEcCtD
Quetiapine—Vomiting—Epirubicin—pancreatic cancer	3.7e-05	0.000161	CcSEcCtD
Quetiapine—Diarrhoea—Doxorubicin—pancreatic cancer	3.69e-05	0.00016	CcSEcCtD
Quetiapine—Rash—Epirubicin—pancreatic cancer	3.67e-05	0.00016	CcSEcCtD
Quetiapine—Dermatitis—Epirubicin—pancreatic cancer	3.67e-05	0.00016	CcSEcCtD
Quetiapine—Headache—Epirubicin—pancreatic cancer	3.65e-05	0.000159	CcSEcCtD
Quetiapine—Dizziness—Doxorubicin—pancreatic cancer	3.56e-05	0.000155	CcSEcCtD
Quetiapine—Nausea—Epirubicin—pancreatic cancer	3.46e-05	0.00015	CcSEcCtD
Quetiapine—Vomiting—Doxorubicin—pancreatic cancer	3.43e-05	0.000149	CcSEcCtD
Quetiapine—Rash—Doxorubicin—pancreatic cancer	3.4e-05	0.000148	CcSEcCtD
Quetiapine—Dermatitis—Doxorubicin—pancreatic cancer	3.4e-05	0.000148	CcSEcCtD
Quetiapine—Headache—Doxorubicin—pancreatic cancer	3.38e-05	0.000147	CcSEcCtD
Quetiapine—Nausea—Doxorubicin—pancreatic cancer	3.2e-05	0.000139	CcSEcCtD
Quetiapine—CYP2C19—Metabolism—PIK3CD—pancreatic cancer	3.02e-06	1.88e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—SRC—pancreatic cancer	3.02e-06	1.88e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—MMP9—pancreatic cancer	3.02e-06	1.88e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—HRAS—pancreatic cancer	3.01e-06	1.87e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—CTNNB1—pancreatic cancer	3.01e-06	1.87e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—TP53—pancreatic cancer	3.01e-06	1.87e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—KRAS—pancreatic cancer	3.01e-06	1.87e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—KRAS—pancreatic cancer	3.01e-06	1.87e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—HRAS—pancreatic cancer	3.01e-06	1.87e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—CCND1—pancreatic cancer	3e-06	1.87e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—CTNNB1—pancreatic cancer	3e-06	1.87e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—PTEN—pancreatic cancer	3e-06	1.87e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—CCND1—pancreatic cancer	2.99e-06	1.86e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—HRAS—pancreatic cancer	2.99e-06	1.86e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—CXCL8—pancreatic cancer	2.99e-06	1.86e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—VEGFA—pancreatic cancer	2.99e-06	1.86e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—CTNNB1—pancreatic cancer	2.97e-06	1.85e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—TP53—pancreatic cancer	2.97e-06	1.85e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—MMP9—pancreatic cancer	2.97e-06	1.85e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—HRAS—pancreatic cancer	2.97e-06	1.84e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—CTNNB1—pancreatic cancer	2.97e-06	1.84e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—MMP9—pancreatic cancer	2.96e-06	1.84e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—STAT3—pancreatic cancer	2.96e-06	1.84e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—MMP9—pancreatic cancer	2.95e-06	1.84e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—PTEN—pancreatic cancer	2.95e-06	1.84e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—NRAS—pancreatic cancer	2.95e-06	1.83e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—PIK3CD—pancreatic cancer	2.95e-06	1.83e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—PTEN—pancreatic cancer	2.95e-06	1.83e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—MMP9—pancreatic cancer	2.94e-06	1.83e-05	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—PTEN—pancreatic cancer	2.94e-06	1.83e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—PIK3CA—pancreatic cancer	2.94e-06	1.83e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—MYC—pancreatic cancer	2.94e-06	1.83e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—VEGFA—pancreatic cancer	2.94e-06	1.83e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—PTEN—pancreatic cancer	2.94e-06	1.83e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—TGFB1—pancreatic cancer	2.93e-06	1.82e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—HRAS—pancreatic cancer	2.93e-06	1.82e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling by GPCR—AKT1—pancreatic cancer	2.93e-06	1.82e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—PTEN—pancreatic cancer	2.93e-06	1.82e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—MMP9—pancreatic cancer	2.92e-06	1.81e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—STAT3—pancreatic cancer	2.91e-06	1.81e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—MMP9—pancreatic cancer	2.91e-06	1.81e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—NRAS—pancreatic cancer	2.9e-06	1.8e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—PTEN—pancreatic cancer	2.9e-06	1.8e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—PTEN—pancreatic cancer	2.89e-06	1.8e-05	CbGpPWpGaD
Quetiapine—ADRA2A—GPCR downstream signaling—AKT1—pancreatic cancer	2.88e-06	1.79e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—HRAS—pancreatic cancer	2.88e-06	1.79e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling by GPCR—AKT1—pancreatic cancer	2.88e-06	1.79e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—EGFR—pancreatic cancer	2.88e-06	1.79e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling by GPCR—AKT1—pancreatic cancer	2.87e-06	1.79e-05	CbGpPWpGaD
Quetiapine—CYP3A7—Metabolism—PIK3CA—pancreatic cancer	2.87e-06	1.79e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling by GPCR—AKT1—pancreatic cancer	2.86e-06	1.78e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—CASP3—pancreatic cancer	2.86e-06	1.78e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling by GPCR—AKT1—pancreatic cancer	2.85e-06	1.78e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—TP53—pancreatic cancer	2.85e-06	1.77e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—HRAS—pancreatic cancer	2.84e-06	1.77e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—MYC—pancreatic cancer	2.84e-06	1.77e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—TGFB1—pancreatic cancer	2.83e-06	1.76e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling by GPCR—AKT1—pancreatic cancer	2.83e-06	1.76e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—MYC—pancreatic cancer	2.82e-06	1.76e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling by GPCR—AKT1—pancreatic cancer	2.82e-06	1.75e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—TGFB1—pancreatic cancer	2.82e-06	1.75e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—TYMS—pancreatic cancer	2.82e-06	1.75e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—PIK3CA—pancreatic cancer	2.8e-06	1.74e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Metabolism—PIK3CA—pancreatic cancer	2.79e-06	1.73e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—CCND1—pancreatic cancer	2.78e-06	1.73e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—SRC—pancreatic cancer	2.78e-06	1.73e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	2.78e-06	1.73e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—EGFR—pancreatic cancer	2.78e-06	1.73e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—PIK3CA—pancreatic cancer	2.77e-06	1.72e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—PIK3CA—pancreatic cancer	2.77e-06	1.72e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—EGFR—pancreatic cancer	2.76e-06	1.72e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—CTNNB1—pancreatic cancer	2.76e-06	1.71e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—MYC—pancreatic cancer	2.75e-06	1.71e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—TGFB1—pancreatic cancer	2.74e-06	1.7e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—SRC—pancreatic cancer	2.74e-06	1.7e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—SRC—pancreatic cancer	2.73e-06	1.7e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—SRC—pancreatic cancer	2.72e-06	1.69e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—HRAS—pancreatic cancer	2.72e-06	1.69e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—KRAS—pancreatic cancer	2.72e-06	1.69e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—SRC—pancreatic cancer	2.71e-06	1.69e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—TP53—pancreatic cancer	2.71e-06	1.69e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—VEGFA—pancreatic cancer	2.71e-06	1.68e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—MYC—pancreatic cancer	2.7e-06	1.68e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—MMP9—pancreatic cancer	2.7e-06	1.68e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—TGFB1—pancreatic cancer	2.7e-06	1.68e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—SRC—pancreatic cancer	2.69e-06	1.67e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—EGFR—pancreatic cancer	2.69e-06	1.67e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—PTEN—pancreatic cancer	2.69e-06	1.67e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—STAT3—pancreatic cancer	2.68e-06	1.67e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—SRC—pancreatic cancer	2.68e-06	1.67e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—NRAS—pancreatic cancer	2.68e-06	1.66e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—TP53—pancreatic cancer	2.68e-06	1.66e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—TP53—pancreatic cancer	2.68e-06	1.66e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—VEGFA—pancreatic cancer	2.67e-06	1.66e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—VEGFA—pancreatic cancer	2.66e-06	1.65e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—AKT1—pancreatic cancer	2.66e-06	1.65e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—AKT1—pancreatic cancer	2.66e-06	1.65e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—VEGFA—pancreatic cancer	2.65e-06	1.65e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—EGFR—pancreatic cancer	2.64e-06	1.64e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—VEGFA—pancreatic cancer	2.64e-06	1.64e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—AKT1—pancreatic cancer	2.64e-06	1.64e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—STAT3—pancreatic cancer	2.64e-06	1.64e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—STAT3—pancreatic cancer	2.63e-06	1.64e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—NRAS—pancreatic cancer	2.63e-06	1.64e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—PIK3CB—pancreatic cancer	2.63e-06	1.64e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—NRAS—pancreatic cancer	2.63e-06	1.63e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—STAT3—pancreatic cancer	2.63e-06	1.63e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—KRAS—pancreatic cancer	2.62e-06	1.63e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—AKT1—pancreatic cancer	2.62e-06	1.63e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—NRAS—pancreatic cancer	2.62e-06	1.63e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—VEGFA—pancreatic cancer	2.62e-06	1.63e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—STAT3—pancreatic cancer	2.62e-06	1.63e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—NRAS—pancreatic cancer	2.61e-06	1.62e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—VEGFA—pancreatic cancer	2.61e-06	1.62e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—KRAS—pancreatic cancer	2.61e-06	1.62e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—PTGS2—pancreatic cancer	2.61e-06	1.62e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—HRAS—pancreatic cancer	2.59e-06	1.61e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—STAT3—pancreatic cancer	2.59e-06	1.61e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—NRAS—pancreatic cancer	2.59e-06	1.61e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—AKT1—pancreatic cancer	2.58e-06	1.61e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—STAT3—pancreatic cancer	2.58e-06	1.61e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—NRAS—pancreatic cancer	2.58e-06	1.6e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—PIK3CB—pancreatic cancer	2.57e-06	1.6e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—HRAS—pancreatic cancer	2.56e-06	1.59e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—HRAS—pancreatic cancer	2.56e-06	1.59e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—PTGS2—pancreatic cancer	2.55e-06	1.58e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—AKT1—pancreatic cancer	2.54e-06	1.58e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—KRAS—pancreatic cancer	2.54e-06	1.58e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—AKT1—pancreatic cancer	2.51e-06	1.56e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—KRAS—pancreatic cancer	2.5e-06	1.55e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—PIK3CA—pancreatic cancer	2.5e-06	1.55e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—MYC—pancreatic cancer	2.49e-06	1.55e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—SRC—pancreatic cancer	2.49e-06	1.55e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—TGFB1—pancreatic cancer	2.49e-06	1.55e-05	CbGpPWpGaD
Quetiapine—CHRM3—Metabolism—PIK3CA—pancreatic cancer	2.47e-06	1.54e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—MYC—pancreatic cancer	2.45e-06	1.53e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—MYC—pancreatic cancer	2.45e-06	1.52e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—TGFB1—pancreatic cancer	2.45e-06	1.52e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—TGFB1—pancreatic cancer	2.44e-06	1.52e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—MYC—pancreatic cancer	2.44e-06	1.52e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—EGFR—pancreatic cancer	2.44e-06	1.52e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—TGFB1—pancreatic cancer	2.43e-06	1.51e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—MYC—pancreatic cancer	2.43e-06	1.51e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—TGFB1—pancreatic cancer	2.43e-06	1.51e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—VEGFA—pancreatic cancer	2.43e-06	1.51e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	2.42e-06	1.51e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—TP53—pancreatic cancer	2.42e-06	1.5e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—PIK3CA—pancreatic cancer	2.41e-06	1.5e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—MYC—pancreatic cancer	2.41e-06	1.5e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—AKT1—pancreatic cancer	2.4e-06	1.49e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—TGFB1—pancreatic cancer	2.4e-06	1.49e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—MYC—pancreatic cancer	2.4e-06	1.49e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—STAT3—pancreatic cancer	2.4e-06	1.49e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PTGS2—pancreatic cancer	2.4e-06	1.49e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—EGFR—pancreatic cancer	2.4e-06	1.49e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—PIK3CA—pancreatic cancer	2.4e-06	1.49e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—TGFB1—pancreatic cancer	2.4e-06	1.49e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—NRAS—pancreatic cancer	2.4e-06	1.49e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—EGFR—pancreatic cancer	2.39e-06	1.49e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—EGFR—pancreatic cancer	2.39e-06	1.48e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—EGFR—pancreatic cancer	2.38e-06	1.48e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—EGFR—pancreatic cancer	2.36e-06	1.46e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—EGFR—pancreatic cancer	2.35e-06	1.46e-05	CbGpPWpGaD
Quetiapine—CYP3A7—Metabolism—AKT1—pancreatic cancer	2.35e-06	1.46e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—PIK3CA—pancreatic cancer	2.33e-06	1.45e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—TP53—pancreatic cancer	2.33e-06	1.45e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—TP53—pancreatic cancer	2.32e-06	1.44e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—HRAS—pancreatic cancer	2.31e-06	1.44e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—KRAS—pancreatic cancer	2.3e-06	1.43e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—PIK3CA—pancreatic cancer	2.3e-06	1.43e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—AKT1—pancreatic cancer	2.29e-06	1.42e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—APOE—pancreatic cancer	2.29e-06	1.42e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Metabolism—AKT1—pancreatic cancer	2.28e-06	1.42e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—PTEN—pancreatic cancer	2.28e-06	1.41e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—KRAS—pancreatic cancer	2.27e-06	1.41e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—PIK3CA—pancreatic cancer	2.27e-06	1.41e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—KRAS—pancreatic cancer	2.26e-06	1.41e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—AKT1—pancreatic cancer	2.26e-06	1.4e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—AKT1—pancreatic cancer	2.26e-06	1.4e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—TP53—pancreatic cancer	2.26e-06	1.4e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—KRAS—pancreatic cancer	2.25e-06	1.4e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—KRAS—pancreatic cancer	2.25e-06	1.4e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—MYC—pancreatic cancer	2.23e-06	1.39e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—HRAS—pancreatic cancer	2.23e-06	1.39e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—TGFB1—pancreatic cancer	2.23e-06	1.38e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—KRAS—pancreatic cancer	2.23e-06	1.38e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—PTEN—pancreatic cancer	2.22e-06	1.38e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—TP53—pancreatic cancer	2.22e-06	1.38e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—KRAS—pancreatic cancer	2.22e-06	1.38e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—HRAS—pancreatic cancer	2.22e-06	1.38e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—EGFR—pancreatic cancer	2.18e-06	1.36e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—HRAS—pancreatic cancer	2.16e-06	1.34e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—HRAS—pancreatic cancer	2.12e-06	1.32e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—PIK3CA—pancreatic cancer	2.12e-06	1.32e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PTEN—pancreatic cancer	2.09e-06	1.3e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—PIK3CA—pancreatic cancer	2.08e-06	1.29e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—PIK3CA—pancreatic cancer	2.08e-06	1.29e-05	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—PIK3CA—pancreatic cancer	2.08e-06	1.29e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—PIK3CA—pancreatic cancer	2.07e-06	1.29e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	2.07e-06	1.28e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—PIK3CA—pancreatic cancer	2.06e-06	1.28e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—KRAS—pancreatic cancer	2.06e-06	1.28e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—TP53—pancreatic cancer	2.05e-06	1.27e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—PIK3CA—pancreatic cancer	2.04e-06	1.27e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—AKT1—pancreatic cancer	2.04e-06	1.27e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—PIK3CA—pancreatic cancer	2.04e-06	1.27e-05	CbGpPWpGaD
Quetiapine—CHRM3—Metabolism—AKT1—pancreatic cancer	2.02e-06	1.25e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—TP53—pancreatic cancer	2.01e-06	1.25e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—TP53—pancreatic cancer	2.01e-06	1.25e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—TP53—pancreatic cancer	2e-06	1.25e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—TP53—pancreatic cancer	2e-06	1.24e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PPARG—pancreatic cancer	1.99e-06	1.24e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—TP53—pancreatic cancer	1.98e-06	1.23e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—TP53—pancreatic cancer	1.97e-06	1.23e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—AKT1—pancreatic cancer	1.97e-06	1.22e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—AKT1—pancreatic cancer	1.96e-06	1.22e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—HRAS—pancreatic cancer	1.96e-06	1.22e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—HRAS—pancreatic cancer	1.93e-06	1.2e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—HRAS—pancreatic cancer	1.92e-06	1.2e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—HRAS—pancreatic cancer	1.92e-06	1.19e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—HRAS—pancreatic cancer	1.91e-06	1.19e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—AKT1—pancreatic cancer	1.91e-06	1.18e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—PIK3CA—pancreatic cancer	1.89e-06	1.18e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—HRAS—pancreatic cancer	1.89e-06	1.18e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—HRAS—pancreatic cancer	1.89e-06	1.17e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—AKT1—pancreatic cancer	1.88e-06	1.17e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—AKT1—pancreatic cancer	1.85e-06	1.15e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—TP53—pancreatic cancer	1.83e-06	1.14e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	1.82e-06	1.13e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—HRAS—pancreatic cancer	1.75e-06	1.09e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—AKT1—pancreatic cancer	1.73e-06	1.07e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—AKT1—pancreatic cancer	1.7e-06	1.06e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—AKT1—pancreatic cancer	1.7e-06	1.06e-05	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—AKT1—pancreatic cancer	1.7e-06	1.05e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—AKT1—pancreatic cancer	1.69e-06	1.05e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—AKT1—pancreatic cancer	1.69e-06	1.05e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—AKT1—pancreatic cancer	1.67e-06	1.04e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—AKT1—pancreatic cancer	1.67e-06	1.04e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—PIK3CA—pancreatic cancer	1.61e-06	9.98e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	1.58e-06	9.84e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PTGS2—pancreatic cancer	1.57e-06	9.75e-06	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—PIK3CA—pancreatic cancer	1.57e-06	9.74e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—AKT1—pancreatic cancer	1.55e-06	9.62e-06	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	1.48e-06	9.18e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PTEN—pancreatic cancer	1.37e-06	8.51e-06	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—AKT1—pancreatic cancer	1.31e-06	8.15e-06	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—AKT1—pancreatic cancer	1.28e-06	7.96e-06	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—AKT1—pancreatic cancer	1.21e-06	7.5e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	9.65e-07	6e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—AKT1—pancreatic cancer	7.88e-07	4.9e-06	CbGpPWpGaD
